Pemmaraju, Naveen
The University of Texas MD Anderson Cancer Center,
United States
2025 Rank: 39,595
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 760 out of 166,615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 39,595 | 29,670 |
| Total Cites | 2,131 | 2,619 |
| H-index | 18 | 22 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 3 | 4 |
| Number of Single+First Authored Papers | 65 | 65 |
| Total Cites to Single+First Authored Papers | 195 | 258 |
| Number of Single+First+Last Authored Papers | 123 | 123 |
| Total Cites to Single+First+Last Authored Papers | 344 | 443 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1,441 | 1,598 |
| Ratio of Total Citations to Distinct Citing Papers | 1.48 | 1.64 |
| Self-Citation Percentage |
18.63%
|
|
Pemmaraju, Naveen
The University of Texas MD Anderson Cancer Center,
United States
2024 Rank: 43,409
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 886 out of 157,372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 43,409 | 27,553 |
| Total Cites | 1,908 | 2,468 |
| H-index | 19 | 22 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 3 | 5 |
| Number of Single+First Authored Papers | 62 | 62 |
| Total Cites to Single+First Authored Papers | 175 | 248 |
| Number of Single+First+Last Authored Papers | 112 | 112 |
| Total Cites to Single+First+Last Authored Papers | 289 | 410 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 1,264 | 1,413 |
| Ratio of Total Citations to Distinct Citing Papers | 1.51 | 1.75 |
| Self-Citation Percentage |
22.69%
|
|
Pemmaraju, Naveen
The University of Texas MD Anderson Cancer Center,
United States
2023 Rank: 64,152
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,436 out of 147,556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 64,152 | 35,006 |
| Total Cites | 1,510 | 2,042 |
| H-index | 16 | 20 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 4 | 9 |
| Number of Single+First Authored Papers | 58 | 58 |
| Total Cites to Single+First Authored Papers | 133 | 189 |
| Number of Single+First+Last Authored Papers | 104 | 104 |
| Total Cites to Single+First+Last Authored Papers | 199 | 296 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 1,115 | 1,288 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.59 |
| Self-Citation Percentage |
26.05%
|
|
Pemmaraju, Naveen
University of Texas MD Anderson Cancer Center,
United States
2022 Rank: 46,459
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,174 out of 138,599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 46,459 | 31,203 |
| Total Cites | 1,514 | 1,934 |
| H-index | 18 | 19 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 5 | 12 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 160 | 205 |
| Number of Single+First+Last Authored Papers | 84 | 84 |
| Total Cites to Single+First+Last Authored Papers | 210 | 285 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 1,150 | 1,318 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.47 |
| Self-Citation Percentage |
21.72%
|
|
Pemmaraju, Naveen
University of Texas MD Anderson Cancer Center,
United States
2021 Rank: 46,108
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,073 out of 127,911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 46,108 | 31,030 |
| Total Cites | 1,918 | 2,423 |
| H-index | 21 | 25 |
| Hm-index | 6 | 8 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 9 | 15 |
| Number of Single+First Authored Papers | 42 | 42 |
| Total Cites to Single+First Authored Papers | 227 | 287 |
| Number of Single+First+Last Authored Papers | 68 | 68 |
| Total Cites to Single+First+Last Authored Papers | 305 | 386 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1,505 | 1,728 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.40 |
| Self-Citation Percentage |
20.84%
|
|
Pemmaraju, Naveen
University of Texas MD Anderson Cancer Center,
United States
2020 Rank: 59,091
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,267 out of 108,509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 59,091 | 51,501 |
| Total Cites | 1,129 | 1,387 |
| H-index | 16 | 18 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 9 | 12 |
| Number of Single+First Authored Papers | 41 | 41 |
| Total Cites to Single+First Authored Papers | 128 | 160 |
| Number of Single+First+Last Authored Papers | 60 | 60 |
| Total Cites to Single+First+Last Authored Papers | 165 | 200 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 887 | 1,010 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.37 |
| Self-Citation Percentage |
18.60%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.